Castration-induced epithelial cell death in human prostate tissue is related to locally reduced IGF-1 levels

Nina Ohlson1, Anders Bergh, Pär Stattin

  • 1Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.

The Prostate
|September 26, 2006
PubMed
Abstract

Insights

Castration reduces prostate insulin-like growth factor (IGF)-1 in humans, but not in malignant tissue. Low androgen receptor (AR) expression may limit prostate cancer cell death after castration therapy.

Area of Science:

  • Urology
  • Endocrinology
  • Cancer Biology

Background:

  • Prostate cancer progression is linked to insulin-like growth factor (IGF)-1 signaling.
  • Castration therapy aims to reduce androgens, impacting prostate tissue.

Purpose of the Study:

  • To investigate the role of IGF-1 in human prostate cancer regression after castration.
  • To determine if stroma IGF-1 changes correlate with epithelial apoptosis and androgen receptor (AR) expression.

Main Methods:

  • Micro-dissection of epithelial and stroma cells from patient biopsies before and after castration.
  • Quantification of IGF-1 mRNA via RT-PCR.
  • Assessment of IGF-1, IGF-1 receptor, and AR immunoreactivity.

Main Results:

  • IGF-1 mRNA predominantly found in stroma; IGF-1 receptor in epithelium.
  • Stroma IGF-1 mRNA decreased post-castration in non-malignant tissue, but not malignant tissue.
  • Reduced stroma IGF-1 post-castration correlated with epithelial apoptosis.
  • Low stroma AR expression before therapy was linked to lack of stroma IGF-1 reduction.

Conclusions:

  • Maintained stroma IGF-1 synthesis, potentially due to low AR expression, may impede prostate cancer cell death following castration.
  • Findings suggest a mechanism where androgen receptor signaling influences IGF-1's role in castration resistance.

Related Concept Videos